Your session is about to expire
← Back to Search
Patient Navigator for Positive Stool Test Follow-Up
Study Summary
This trial will test whether a patient navigator can help improve follow-up care after a stool test shows blood or other abnormal markers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not understand English.
- Group 1: Patient navigator
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must be met to meet the requirements for this clinical trial?
"Eligibility into this clinical trial requires positive fit or stool dna testing results and subjects must be between 40-75 years of age. A maximum of 30 participants can apply to partake in the study."
Is the research team still accepting new participants for this clinical experiment?
"Correct. Clinicaltrials.gov lists this clinical trial as currently open to participants, which was first posted on September 1st 2019 and updated on July 5th 2022. The study is looking for 30 patients across a single site."
What is the magnitude of participants in this investigation?
"Affirmative. According to the information hosted on clinicaltrials.gov, this trial is presently recruiting participants since its inception in September 1st 2019 and most recent update of July 5th 2022. In total, 30 candidates are expected to be enrolled from a single medical facility."
Does this experiment accept participants who have surpassed the age of 20?
"In line with the trial requirements, individuals aged between 40 and 75 are eligible to join this clinical study."
Share this study with friends
Copy Link
Messenger